Investors with over $100,000 in Erasca losses must submit lead plaintiff applications by August 10, 2026 in the ongoing securities class action
Executive summary: ClaimsFiler reminded investors with losses over $100,000 in Erasca that they have until August 10, 2026 to file lead plaintiff applications in a securities class action lawsuit against the company. The deadline determines who can lead the litigation, influencing legal strategy and potential settlement outcomes for Erasca and its shareholders.
Who is involved: Erasca, Inc. (Nasdaq: ERAS), the law firm ClaimsFiler, plaintiffs' counsel, and affected investors.
Likely next: After August 10, the court will review lead plaintiff applications and appoint a lead plaintiff, after which the case will proceed to discovery or settlement discussions.
ClaimsFiler issued a reminder that investors who suffered losses exceeding $100,000 in Erasca, Inc. (Nasdaq: ERAS) have until August 10, 2026 to apply for lead plaintiff status in a securities class action lawsuit. The lawsuit, previously announced in July 2026, alleges violations of federal securities laws related to the company's disclosures. The notice does not indicate any new developments in the case beyond the filing deadline. Investors who miss the deadline will be unable to serve as lead plaintiffs but may still participate as class members.
Timeline
- — Erasca Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Erasca - ERAS (PR Newswire)
- — ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA (PR Newswire)
- — Erasca, Inc. (ERAS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
- — INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Erasca, Inc. of Class Action Lawsuit and Upcoming Deadlines - ERAS (PR Newswire)
- — ERAS DEADLINE NOTICE: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit (PR Newswire)
- — Erasca (ERAS) Receives Encouraging Expert Feedback on ERAS-0015 Clinical Trials (Yahoo Finance)
Analysis — what this means
Likely next events
- August 10, 2026: deadline for lead plaintiff applications in the Erasca securities class action lawsuit
Sectors affected
- Biotechnology
- Pharmaceuticals
Regulatory implications
- Potential enforcement of Section 10(b) of the Securities Exchange Act and Rule 10b-5; possible restitution under the Private Securities Litigation Reform Act
Key entities
Sources
Open the full interactive case file on Beyond →
INTELLIGENCE
Social Pulse
AI estimate · not scraped